VEGFA and age-related macular degeneration: Although therapies targeting neovascularization, like intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents and photodynamic therapy (PDT)6–8, have been developed for AMD, treatment resistance, and CNV recurrence have been observed in a non-negligible fraction of patients9–11.